Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of dendritic cells in cancer and anti-tumor immunity
Ariel E. Marciscano, Niroshana Anandasabapathy
Seminars in Immunology (2021) Vol. 52, pp. 101481-101481
Open Access | Times Cited: 170

Showing 26-50 of 170 citing articles:

Tumor microenvironment responsive metal nanoparticles in cancer immunotherapy
Rou Yang, Lu Chen, Yiling Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 20
Multifunctional nanoparticles precisely reprogram the tumor microenvironment and potentiate antitumor immunotherapy after near-infrared-II light-mediated photothermal therapy
Yanni Ge, Jiaojiao Zhang, Kai Jin, et al.
Acta Biomaterialia (2023) Vol. 167, pp. 551-563
Open Access | Times Cited: 19
Aggregation-induced emission photosensitizer/bacteria biohybrids enhance Cerenkov radiation-induced photodynamic therapy by activating anti-tumor immunity for synergistic tumor treatment
Ziyang Zhu, Qingyao Liu, Ke Zhu, et al.
Acta Biomaterialia (2023) Vol. 167, pp. 519-533
Open Access | Times Cited: 19
Tackling the current dilemma of immunotherapy in extensive-stage small cell lung cancer: A promising strategy of combining with radiotherapy
Kai Kang, Yijun Wu, Zhuoran Yao, et al.
Cancer Letters (2023) Vol. 565, pp. 216239-216239
Open Access | Times Cited: 18
Biomimetic nanoparticles for DC vaccination: a versatile approach to boost cancer immunotherapy
Lingyang Meng, Zhuang Teng, Shuang Yang, et al.
Nanoscale (2023) Vol. 15, Iss. 14, pp. 6432-6455
Closed Access | Times Cited: 17
Exosome-mediated crosstalk between tumor cells and innate immune cells: implications for cancer progression and therapeutic strategies
Louis Boafo Kwantwi
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 11, pp. 9487-9503
Closed Access | Times Cited: 17
Antigen presenting cells in cancer immunity and mediation of immune checkpoint blockade
Cassia Wang, Lee Chen, Doris Fu, et al.
Clinical & Experimental Metastasis (2024) Vol. 41, Iss. 4, pp. 333-349
Open Access | Times Cited: 8
Targeting CD8+ T cells with natural products for tumor therapy: Revealing insights into the mechanisms
Yuke Wang, Yan Zeng, Wenyong Yang, et al.
Phytomedicine (2024) Vol. 129, pp. 155608-155608
Closed Access | Times Cited: 8
Up-regulated PLA2G10 in cancer impairs T cell infiltration to dampen immunity
Tianxiang Zhang, Weiwei Yu, Xiaoxiao Cheng, et al.
Science Immunology (2024) Vol. 9, Iss. 94
Closed Access | Times Cited: 7
The rising roles of exosomes in the tumor microenvironment reprogramming and cancer immunotherapy
Yu Wu, Wenyan Han, Hairong Dong, et al.
MedComm (2024) Vol. 5, Iss. 4
Open Access | Times Cited: 6
Construction of Natural Polysaccharide-Based pH-Responsive Gold Nanorods for Combined Photothermal Therapy and Immunotherapy
Zhen Lin, Fan Nie, Zhiyun Zhang, et al.
ACS Applied Nano Materials (2024) Vol. 7, Iss. 9, pp. 10466-10478
Closed Access | Times Cited: 6
Lactobacillus plantarum GUANKE modulate anti-viral function of dendritic cells in mice
Si‐Min Lu, Siqin He, Kun Yue, et al.
International Immunopharmacology (2024) Vol. 134, pp. 112169-112169
Closed Access | Times Cited: 6
Low-intensity focused ultrasound targeted microbubble destruction reduces tumor blood supply and sensitizes anti-PD-L1 immunotherapy
Nianhong Wu, Yuting Cao, Ying Liu, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 16
Delivering co-stimulatory tumor necrosis factor receptor agonism for cancer immunotherapy: past, current and future perspectives
Osman Dadas, Ayse Ertay, Mark S. Cragg
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
Decoding the Impact of Tumor Microenvironment in Osteosarcoma Progression and Metastasis
Bikesh K. Nirala, Taku Yamamichi, D. Isabel Petrescu, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 5108-5108
Open Access | Times Cited: 16
Antigen cross-presentation by dendritic cells: A critical axis in cancer immunotherapy
Christine Moussion, Lélia Delamarre
Seminars in Immunology (2023) Vol. 71, pp. 101848-101848
Closed Access | Times Cited: 15
Cell Immunotherapy against Melanoma: Clinical Trials Review
Ivan Y. Filin, Yuriy P. Mayasin, Chulpan B. Kharisova, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2413-2413
Open Access | Times Cited: 14
The Journey of Cancer Cells to the Brain: Challenges and Opportunities
Marzena Łazarczyk, Michel‐Edwar Mickael, Dominik Skiba, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3854-3854
Open Access | Times Cited: 14
In vivo immunomodulatory activity of fucoidan from brown alga Undaria pinnatifida in sarcoma 180-bearing mice
Qin Li, Xiaoyan Wang, Yisheng Wan, et al.
Journal of Functional Foods (2023) Vol. 103, pp. 105486-105486
Open Access | Times Cited: 14
Trabectedin and Lurbinectedin Modulate the Interplay between Cells in the Tumour Microenvironment—Progresses in Their Use in Combined Cancer Therapy
Adrián Povo‐Retana, Rodrigo Landauro‐Vera, Carlota Alvarez‐Lucena, et al.
Molecules (2024) Vol. 29, Iss. 2, pp. 331-331
Open Access | Times Cited: 5
Immune landscape and response to oncolytic virus-based immunotherapy
Chaolong Lin, Wenzhong Teng, Tian Yang, et al.
Frontiers of Medicine (2024) Vol. 18, Iss. 3, pp. 411-429
Closed Access | Times Cited: 5
Renal cancer: signaling pathways and advances in targeted therapies
Aimin Jiang, Jinxin Li, Ziwei He, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 5
Dendritic cell vaccines improve the glioma microenvironment: Influence, challenges, and future directions
Jing Zhou, Luohong Li, Minqi Jia, et al.
Cancer Medicine (2022) Vol. 12, Iss. 6, pp. 7207-7221
Open Access | Times Cited: 21
Advances in research on immune escape mechanism of glioma
Xu Guo, Gang Wang
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. 7, pp. 1709-1720
Open Access | Times Cited: 11
Tumor vaccines: Toward multidimensional anti-tumor therapies
Yuanfang Tan, H. S. Chen, Xi Gou, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 3
Open Access | Times Cited: 11

Scroll to top